Inside the research
Align Technology, Inc.
ALGN Research profile · latest available data
Price overview
$146.78
▲ +1.15 (+0.8%)
| 52w hi | $197.51 |
|---|---|
| 52w lo | $124.88 |
| Vol | 829.60K |
| As of | 25 Sep 2026 |
The Verdict
Our score -0.19
| Short | -0.38 |
|---|---|
| Medium | -0.11 |
| Long | +0.05 |
computed 2026-09-27
Key fundamentals
Align Technology, Inc.
Healthcare · Medical Instruments & Supplies
| Market cap | $10.43B |
|---|---|
| Enterprise value | $9.45B |
| Trailing P/E | 25.53x |
| Forward P/E | 11.74x |
| EV / EBITDA | 10.20x |
| P / S (ttm) | 2.52x |
| Profit margin | 10.0% |
| Return on equity | 10.2% |
| Revenue growth | +4.3% |
| Earnings growth | -12.1% |
| Debt / equity | 2.85 |
Layer Breakdown
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.20 | |
| Sector | +0.08 | |
| Technical | -0.27 | |
| Earnings | +0.00 | |
| Sentiment | +0.00 |
macro × 1.00 · 2026-09-27
Business overview
Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. This segment also provides Invisalign express, Invisalign lite, and Invisalign moderate; Invisalign Go, Invisalign Go express, and Invisalign Go Plus; retention products, Invisalign training, adjusting tools used by dental professionals during treatment, ancillary Invisalign accessory products, and other oral health products; Invisalign Professional Whitening system; Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; exocad, a computer-aided design and computer-aided manufacturing software; orthodontist software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers; and restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons. This segment also offers Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface for dental consultations; iTero TimeLapse technology for doctors or practitioners to compare a patient's historic 3D scans to the present-day scan; and subscription software, disposables, rents scanners, and pay per scan services. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
Risk Metrics
| Beta vs SPX | 1.34 |
|---|---|
| Corr SPX | 0.46 |
| Annual vol | 47.0% |
| Annual ret | -15.1% |
| Sharpe | -0.32 |
| Max DD | -51.0% |
Window: 504 trading days (504 obs)
Analyst Coverage
| Mean PT | $209.07 |
|---|---|
| High / Low | $240.00 / $175.00 |
| Median | $214.00 |
| Analysts | 14 |
| Strong Buy | 3 | |
|---|---|---|
| Buy | 8 | |
| Hold | 4 | |
| Sell | 0 | |
| Strong Sell | 1 |
Recent rating actions
| 2026-04-30 | Evercore ISI Group | → Outperform |
| 2026-04-24 | Morgan Stanley | → Equal-Weight |
| 2026-04-21 | Piper Sandler | → Overweight |
| 2026-04-15 | Citigroup | → Buy |
| 2026-03-17 | Barclays | → Overweight |
| 2026-02-26 | Barclays | → Equal-Weight |
Material Events
| Date | Event | 8-K |
|---|---|---|
| 2026-07-29 | Reg FD Disclosure, Exhibits | read |
| 2026-07-29 | Earnings Release, Exhibits | read |
| 2026-07-09 | Officer / Director Change | read |
| 2026-06-22 | Officer / Director Change, Reg FD Disclosure… | read |
| 2026-05-20 | Shareholder Vote, Exhibits | read |
| 2026-05-01 | Reg FD Disclosure, Exhibits | read |
| 2026-04-29 | Earnings Release, Exhibits | read |
| 2026-02-26 | Bylaws Amendment, Exhibits | read |
| 2026-02-04 | Earnings Release, Exhibits | read |
| 2025-10-29 | Earnings Release, Exhibits | read |
| 2025-09-18 | Officer / Director Change | read |
| 2025-08-05 | Reg FD Disclosure, Exhibits | read |
Flow & Concentration
| Insider 180d net | $0 |
|---|---|
| Insider buys / sells | 0 / 0 |
| Insider bias | Neutral |
| 13F holders | 9 |
| Top-5 share | 98.4% |
| HHI | 2,688 (concentrated) |
Top Holders
| Holder | Value | Shares |
|---|---|---|
| Fidelity / FMR LLC | $684.77M | 4.06M |
| State Street Corp | $431.52M | 2.56M |
| Capital Research / Capital World | $359.73M | 2.13M |
| AQR Capital Management | $151.16M | 899.73K |
| Citadel Advisors | $86.64M | 513.68K |
| Bridgewater Associates | $13.90M | 82.40K |
| Millennium Management | $12.86M | 76.26K |
| Ark Invest | $887.83K | 5.26K |
| T. Rowe Price Group | $16.53K | 98.01K |
As of 2026-06-30
SEC Filings
The Long Run
FY 2010–2025 · 16 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $4.03B | +18.8% | |
| Gross profit | $2.71B | +17.7% | |
| Operating income | $643.34M | +13.0% | |
| Net income | $445.05M | +14.8% | |
| Cash from ops | $785.78M | +22.0% |
Indices
Recent Sessions
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Sep 25 | $145.57 | $148.17 | $144.20 | $146.78 | 829.60K |
| Sep 24 | $148.65 | $149.22 | $145.27 | $145.63 | 785.80K |
| Sep 23 | $152.50 | $153.40 | $147.07 | $148.17 | 1.33M |
| Sep 22 | $149.17 | $154.10 | $147.62 | $153.29 | 966.90K |
| Sep 21 | $147.97 | $148.37 | $145.55 | $146.88 | 975.80K |
Understand the score. Research layers are inputs to a model, and the available data has limits.
Read the methodology →